Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Crit Care ; 30(2): 436.e1-6, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25483928

RESUMO

PURPOSE: The purpose of this work was to obtain a detailed perspective of sedation practice. Sedation included sedative and opioid choice, presence of local guidelines, and use of scoring systems. METHODS: A Web-based survey was designed. The aim was to gain sufficient detail of UK sedation while also being succinct enough to complete in 15 minutes. It was composed of relevant demographics, policy, sedative choice, and analgesia. The survey was piloted before launch. The investigators selected the intensive care unit (ICU) pharmacist as the respondent. RESULTS: One hundred fifty-seven ICUs responded. Eighty-nine (59%) reported use of sedation guidelines, 78% undertook sedation holds, and 87% use sedation scores. Only 42% used a daily sedation target. Seventy (43%) assess for delirium; 27 of those use a validated tool. Propofol (89%) use was common, followed by midazolam (49%). Morphine (49%), fentanyl (34%), and alfentanil (34%) were the most frequently used opioids. CONCLUSION: This survey confirmed expected variation in UK sedation practice. Recognized strategies such as target sedation score and sedation policy are underused. A 43% uptake in delirium screening suggests that larger engagement is required to meet national standards.


Assuntos
Analgésicos Opioides/uso terapêutico , Sedação Consciente/métodos , Cuidados Críticos/métodos , Sedação Profunda/métodos , Delírio/diagnóstico , Hipnóticos e Sedativos/uso terapêutico , Alfentanil/uso terapêutico , Coleta de Dados , Fentanila/uso terapêutico , Humanos , Unidades de Terapia Intensiva , Internet , Midazolam , Morfina/uso terapêutico , Guias de Prática Clínica como Assunto , Padrões de Prática Médica , Propofol/uso terapêutico , Reino Unido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA